Last, DDX5 has been implicated in several tumors (e.g., NSCLC, breast cancer, gastric cancer, multiple myeloma, glioma) [25,26,27,28,29] through aberrant expression or through the regulation of proliferation, metastasis, and invasion pathways that directly regulate oncogenesis. Here, DDX5 is linked to breast carcinoma.